Sequenceb | Patients (No.) | All Ratersc | Raters 1 and 2 | Raters 1 and 3 | Raters 2 and 3 |
---|---|---|---|---|---|
Analysis 1 | |||||
T2* | 55 | 0.942 (0.915–0.961) | 0.990 (0.981–0.994) | 0.858 (0.758–0.917) | 0.818 (0.689–0.894) |
TSWI | 55 | 0.982 (0.974–0.988) | 0.963 (0.942–0.977) | 0.994 (0.990–0.996) | 0.959 (0.936–0.974) |
tSWI | 55 | 0.991 (0.986–0.994) | 0.979 (0.964–0.988) | 0.997 (0.995–0.998) | 0.984 (0.972–0.991) |
Analysis 2 | |||||
T2* | 25 | 0.959 (0.795–0.944) | 0.992 (0.982–0.996) | 0.911 (0.798–0.961) | 0.882 (0.733–0.948) |
TSWI | 37 | 0.984 (0.972–0.991) | 0.968 (0.938–0.984) | 0.994 (0.988–0.997) | 0.963 (0.929–0.981) |
tSWI | 33 | 0.991 (0.985–0.995) | 0.983 (0.966–0.992) | 0.997 (0.994–0.999) | 0.983 (0.966–0.992) |
↵a Interrater agreement was determined with the intraclass correlation coefficient, and the 95% confidence intervals are given in parenthesis.
↵b Analysis was made twice: 1) for all patients (n = 55) with CMBs, on the basis of the initial KIDS CMB analysis; 2) for all patients with >1 CMB according to Rater 1.
↵c “All Raters” represents analysis among Raters 1, 2, and 3.